Single-Site Study of Naltrexone/Acetaminophen for the Acute Treatment of Migraine: A Phase 2 Randomized Trial

Stopped No participants enrolled; study suspended due to recruitment challenges.

Conditions

• Migraine

Interventions

• DRUG: Stage 1: Naltrexone/Acetaminophen
• DRUG: Stage 1: Naltrexone
• DRUG: Stage 1: Acetaminophen
• DRUG: Stage1: Placebo
• DRUG: Stage 2: Naltrxone/Acetaminophen high dose
• DRUG: Stage 2: Naltrexone/Acetaminophen medium dose
• DRUG: Stage 2: Naltrxone/Acetaminophen low dose
• DRUG: Stage 2: Placebo

Sponsor

Allodynic Therapeutics, Inc